67 related articles for article (PubMed ID: 20661866)
1. Efficient assessment of the most important symptoms in advanced prostate cancer: the NCCN/FACT-P Symptom Index.
Victorson DE; Beaumont JL; Rosenbloom SK; Shevrin D; Cella D
Psychooncology; 2011 Sep; 20(9):977-83. PubMed ID: 20661866
[TBL] [Abstract][Full Text] [Related]
2. Priority symptoms in advanced breast cancer: development and initial validation of the National Comprehensive Cancer Network-Functional Assessment of Cancer Therapy-Breast Cancer Symptom Index (NFBSI-16).
Garcia SF; Rosenbloom SK; Beaumont JL; Merkel D; Von Roenn JH; Rao D; Cella D
Value Health; 2012 Jan; 15(1):183-90. PubMed ID: 22264987
[TBL] [Abstract][Full Text] [Related]
3. The Functional Assessment of Cancer Therapy-Anemia (FACT-An) Scale: a new tool for the assessment of outcomes in cancer anemia and fatigue.
Cella D
Semin Hematol; 1997 Jul; 34(3 Suppl 2):13-9. PubMed ID: 9253779
[TBL] [Abstract][Full Text] [Related]
4. Development of a multidimensional measure for recurrent abdominal pain in children: population-based studies in three settings.
Malaty HM; Abudayyeh S; O'Malley KJ; Wilsey MJ; Fraley K; Gilger MA; Hollier D; Graham DY; Rabeneck L
Pediatrics; 2005 Feb; 115(2):e210-5. PubMed ID: 15687428
[TBL] [Abstract][Full Text] [Related]
5. Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument.
Esper P; Mo F; Chodak G; Sinner M; Cella D; Pienta KJ
Urology; 1997 Dec; 50(6):920-8. PubMed ID: 9426724
[TBL] [Abstract][Full Text] [Related]
6. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
Park KU
Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
[TBL] [Abstract][Full Text] [Related]
7. Visual analog scale questionnaire to assess quality of life specific to each symptom of the International Prostate Symptom Score.
Ushijima S; Ukimura O; Okihara K; Mizutani Y; Kawauchi A; Miki T
J Urol; 2006 Aug; 176(2):665-71. PubMed ID: 16813918
[TBL] [Abstract][Full Text] [Related]
8. Early quality of life assessment in men treated with permanent source interstitial brachytherapy for clinically localized prostate cancer.
Lee WR; McQuellon RP; Case LD; deGuzman AF; McCullough DL
J Urol; 1999 Aug; 162(2):403-6. PubMed ID: 10411047
[TBL] [Abstract][Full Text] [Related]
9. Differences in health-related quality of life of prostate cancer patients based on stage of cancer.
Rosenfeld B; Roth AJ; Gandhi S; Penson D
Psychooncology; 2004 Nov; 13(11):800-7. PubMed ID: 15386638
[TBL] [Abstract][Full Text] [Related]
10. Cancer-related pain and quality of life in prostate cancer patients: assessment using the Functional Assessment of Prostate Cancer Therapy.
Fujimura T; Takahashi S; Kume H; Takeuchi T; ; Kitamura T; Homma Y
Int J Urol; 2009 May; 16(5):522-5. PubMed ID: 19383037
[TBL] [Abstract][Full Text] [Related]
11. Computerized symptom and quality-of-life assessment for patients with cancer part I: development and pilot testing.
Berry DL; Trigg LJ; Lober WB; Karras BT; Galligan ML; Austin-Seymour M; Martin S
Oncol Nurs Forum; 2004 Sep; 31(5):E75-83. PubMed ID: 15378104
[TBL] [Abstract][Full Text] [Related]
12. Osteoporosis risk and interest in strength training in men receiving androgen ablation therapy for locally advanced prostate cancer.
Ott C; Fulton MK
J Am Acad Nurse Pract; 2005 Mar; 17(3):113-22. PubMed ID: 15748224
[TBL] [Abstract][Full Text] [Related]
13. A prospective analysis of patient-reported quality of life after prostate brachytherapy.
Lee WR; McQuellon RP; McCullough DL
Semin Urol Oncol; 2000 May; 18(2):147-51. PubMed ID: 10875457
[TBL] [Abstract][Full Text] [Related]
14. Radical retropubic prostatectomy reduces symptom scores and improves quality of life in men with moderate and severe lower urinary tract symptoms.
Schwartz EJ; Lepor H
J Urol; 1999 Apr; 161(4):1185-8. PubMed ID: 10081866
[TBL] [Abstract][Full Text] [Related]
15. A prospective quality of life study in patients with locally advanced prostate cancer, treated with radiotherapy with or without regional or interstitial hyperthermia.
Van Vulpen M; De Leeuw JR; Van Gellekom MP; Van Der Hoeven J; De Graeff A; Van Moorselaar RJ; Van Der Tweel I; Hofman P; Lagendijk JJ; Battermann JJ
Int J Hyperthermia; 2003; 19(4):402-13. PubMed ID: 12850926
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a new treatment outcome score for men with LUTS.
Weiss JP; Blaivas JG; Tash Anger JA; Di Blasio CJ; Panagopoulos G; Gerboc J
Neurourol Urodyn; 2004; 23(2):88-93. PubMed ID: 14983416
[TBL] [Abstract][Full Text] [Related]
17. Quality of life in prostate cancer patients and controls: psychometric validation of the FACTP-4 in Spanish, and relation to urinary symptoms.
Batista-Miranda JE; Sevilla-Cecilia C; Torrubia R; Musquera M; Huguet-Pérez J; Ponce de León X; Rosales Bordes A; Salvador Bayarri J; Villavicencio Mavrich H
Arch Esp Urol; 2003 May; 56(4):447-54. PubMed ID: 12830620
[TBL] [Abstract][Full Text] [Related]
18. Expanded Prostate Cancer Index Composite versus Incontinence Symptom Index and Sexual Health Inventory for Men to measure functional outcomes after prostatectomy.
Hedgepeth RC; Labo J; Zhang L; Wood DP
J Urol; 2009 Jul; 182(1):221-7; discussion 227-8. PubMed ID: 19450842
[TBL] [Abstract][Full Text] [Related]
19. The ability of existing questionnaires to measure symptom change after paracentesis for symptomatic ascites.
Easson AM; Bezjak A; Ross S; Wright JG
Ann Surg Oncol; 2007 Aug; 14(8):2348-57. PubMed ID: 17505860
[TBL] [Abstract][Full Text] [Related]
20. [Quality of life among patients with advanced prostate cancer: a survey using functional assessment of cancer therapy-prostate in China].
Zhang K; Gong K; Zhou LQ; Na YQ
Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(10):665-8. PubMed ID: 18642765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
